By continuing to use the site, you allow the use of Cookies and agree to the privacy policy.
.,о.,р..и.:г,.и.,н.;н.,а;,л.. .,н.:а,.х.,о.,д.;и.,т..с.:я,, ..н.;а., .,k;,i..b.:e,;r.,i.,s.,.;.r.:u,

E45 Retarded development following protein-energy malnutrition

AddCompare
Found partially in the 53 (51) ⓘFound partially in the 53 drug (51 of these, according to Kiberis statistics) in 0 selected books (authors) ... hide
  Effect Influence Cases ⓘ  Effect - how much the symptom improves in one treatment cycle on average. Example: drug Pain relief for cancer pain-Effectiveness (E) is high, but the effect (I) negative, because the patient will get worse over time.
Influence of the symptom on the outcome of the patient's treatment as a whole (i.e., the importance of the symptom). Example: menopause can not be cured (E low). But some means during menopause will be better than others (I high).
Cases - the number of investigated treatment results for a given complaint, on the basis of which the effect and effect were calculated. These cases have already passed automatic AI verification of data quality and reliability.
  • e45 retarded development following protein-energy malnutrition
  • 70%+21%9   Hidden. Need a subscription
  • 61%+32%6 read Aconitum napellus
  • 51%-4%20 read Mucosa compositum
  • 47%-15%26 read Chininum arsenicosum
  • 45%-3%8 read Pumpan
  • 43%+18%10 read Ferrum metallicum
  • 36%-5%21 read Echinacea compositum sn
  • 36%-2%24 read Arnica montana
  • 35%-6%27 read China officinalis
  • 34%+6%42 read Calcarea carbonica
    Scanty - E 34% (I 6%, 42 cases.); Lags behind in the development - E 32% (I 8%, 20 cases.)

    скудные,отстает в развитии

    • 58% +23% 5 with «constipation»
    • 50% +27% 5 with «thirst»
    • 50% +21% 4 with «fear of loud noises»
    • 50% +21% 4 with «fear of talking»
    • 50% +21% 4 with «loud voice»
    • 46% +16% 4 with «night sweating»
    • 46% +16% 4 with «night sweat»
    • 46% +16% 4 with «excessive sweating at night»
    • 46% +16% 4 with «sweating during the day»
    • On average: 32% 8% 20 
    • 12% -4% 4 with «rashes on the head»
    • 5% +0% 4 with «allergy»
    • 0% -17% 4 with «inflammation»
  • 33%+6%53 read Lycopodium clavatum
    Scanty - E 33% (I 6%, 53 cases.); Lags behind in the development - E 19% (I -1%, 15 cases.)
  • 33%+3%18 read Carbo vegetabilis
    Scanty - E 33% (I 3%, 18 cases.); Lags behind in the development - E 17% (I -15%, 12 cases.)
  • 33%-4%24 read Bryonia alba
  • 31%+1%19 read Medorrhinum
    Scanty - E 31% (I 1%, 19 cases.); Lags behind in the development - E 33% (I -2%, 15 cases.)

    скудные,отстает в развитии

    • On average: 33% -2% 15 
    • 27% -1% 6 with «hyperactive»
    • 27% -1% 6 with «fidgety»
    • 14% +1% 4 with «sweating is increased»
  • 30%-4%6 read Veratrum album
  • 29%-2%43 read Kalium carbonicum
  • 28%+4%7 read Naja tripudians
  • 27%+23%6 read Tarentula hispanica
  • 27%+8%11 read Argentum nitricum
  • 26%+0%26 read Rhus toxicodendron
  • 26%-14%8 read Chamomilla vulgaris
  • 25%-6%35 read Causticum hahnemanni
    Scanty - E 25% (I -6%, 35 cases.); Lags behind in the development - E 50% (I 10%, 3 cases.)
  • 25%+1%72 read Pulsatilla nigricans
    Scanty - E 25% (I 1%, 72 cases.); Lags behind in the development - E 31% (I 6%, 10 cases.)

    скудные,отстает в развитии

    • 45% +12% 3 with «indecision»
    • On average: 31% 6% 10 
  • 24%-5%22 read Calcarea phosphorica
    Scanty - E 24% (I -5%, 22 cases.); Lags behind in the development - E 7% (I -24%, 8 cases.)
  • 24%-19%5 read Discus compositum
  • 24%+8%23 read Staphysagria
  • 24%+2%72 read Natrum muriaticum
    Scanty - E 24% (I 2%, 72 cases.); Lags behind in the development - E 12% (I -4%, 18 cases.)

    скудные,отстает в развитии

    • On average: 12% -4% 18 
    • 5% -12% 5 with «aggressive»
    • 5% -4% 5 with «sweating is increased»
    • 0% -12% 4 with «inflammation»
    • 0% -11% 2 with «squeamishness»
  • 23%+0%6 read Spongia tosta
  • 23%-1%58 read Lachesis muta
    Scanty - E 23% (I -1%, 58 cases.); Lags behind in the development - E 16% (I -2%, 6 cases.)
  • 23%-2%41 read Sepia officinalis
  • 23%+7%9 read Graphites naturalis
  • 23%+5%4 read Cina maritima
  • 22%-8%14 read Ignatia amara
  • 20%-3%92 read Phosphorus
    Scanty - E 20% (I -3%, 92 cases.); Lags behind in the development - E 9% (I -22%, 6 cases.)
  • 20%-6%40 read Arsenicum album
    Scanty - E 20% (I -6%, 40 cases.); Lags behind in the development - E 51% (I 8%, 4 cases.)
  • 20%-5%60 read Sulphur
    Scanty - E 20% (I -5%, 60 cases.); Lags behind in the development - E 30% (I 10%, 25 cases.)

    скудные,отстает в развитии

    • 65% +26% 4 with «poor sleep»
    • 65% +26% 4 with «can not sleep»
    • 65% +26% 4 with «cannot sleep»
    • 65% +26% 4 with «prolonged insomnia»
    • On average: 30% 10% 25 
    • 3% -26% 4 with «allergy»
    • 3% -10% 5 with «itchy skin»
    • 0% -12% 6 with «inflammation»
    • 0% -17% 4 with «fearfulness»
  • 19%-3%29 read Thuja occidentalis
    Scanty - E 19% (I -3%, 29 cases.); Lags behind in the development - E 29% (I 6%, 10 cases.)
  • 17%-13%18 read Crotalus horridus
  • 17%+0%31 read Silica terra
  • 15%-4%24 read Tuberculinum bovinum kent
    Scanty - E 15% (I -4%, 24 cases.); Lags behind in the development - E 33% (I 3%, 22 cases.)

    скудные,отстает в развитии

    • 50% +9% 2 with «no thirst»
    • On average: 33% 3% 22 
    • 22% -6% 5 with «sociable»
  • 14%-4%35 read Nux vomica
    Scanty - E 14% (I -4%, 35 cases.); Lags behind in the development - E 11% (I 7%, 8 cases.)

    скудные,отстает в развитии

    • On average: 11% 7% 8 
    • 0% +6% 4 with «aggressive»
  • 14%-8%10 read Kali bichromicum
  • 13%-10%40 read Natrum sulphuricum
  • 9%+5%6 read Zincum metallicum
  • 9%-17%17 read Belladonna
  • 8%-13%10 read Conium maculatum
  • 6%-7%9 read Hepar sulphuris calcareum
  • 3%+4%14 read Kali phosphoricum
  • 3%-13%15 read Galium-heel
  • 2%-30%11 read Baryta carbonica
    Scanty - E 2% (I -30%, 11 cases.); Lags behind in the development - E 18% (I -5%, 26 cases.)
  • 0%-7%5 read Hyoscyamus niger
    Scanty - E 0% (I -7%, 5 cases.); Lags behind in the development - E 42% (I 14%, 11 cases.)

    скудные,отстает в развитии

    • 65% +26% 4 with «neurosis»
    • On average: 42% 14% 11 
  • Stramonium read
  • Syphilinum read

Tree of ICD-10 diagnoses



  1. Kiberis is NOT an online store and does NOT purchase, store, sell or deliver drugs. The resource acts only as an intermediary between you and the manufacturer of drugs or pharmacy points, which carry out the delivery.
  2. On Kiberis there are descriptions of drugs, some of which are intended only for doctors. This information cannot be used by patients to make decisions about the use of drugs, their cancellation or correction of dosages.
  3. Nothing in the information provided should be interpreted as a call to use these drugs.
  4. No claims can be made to Kiberis regarding any damage or harm incurred as a result of the use of the information posted on the site.